British Medical Bulletin 47:484-492 (1991)
© 1991 The British Council
research-article |
Oestrogens and breast cancer: Exogenous hormones
Department of Public Health and Primary Care, Radcliffe Infirmary Oxford, UK
Abstract
Oestrogens are administered to women as contraceptive agents and as treatment for menopausal symptons. This article reviews the epidemiological evidence concerning the risk of breast cancer related to both types of medication. It is generally accepted that long-term, high-close menopausal oestrogen administration with a moderate increase in breast cancer the risk of benign breast disease (as well as ovarian and endometrial cancer). The effect of oral contraceptives on breast cancer risk, however, is less certain. Possible reasons for the lack of agreement between recently conducted case-control studies are discussed, concentrating specifically on the effect of possible latency, being the sum of a prolonged induction plus pre-clinical period, in explaining the discrepancies.